Diffuse alopecia areata

disease
On this page

Also known as alopecia celsiCazenave's vitiligoCelsus' vitiligoJonston's alopeciamarginal alopeciapatchy alopecia

Summary

Diffuse alopecia areata (MONDO:0000687) is a disease. A subtype of alopecia areata — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namediffuse alopecia areata
Mondo IDMONDO:0000687
MeSHC531609
DOIDDOID:0060157
ICD-11666274267
SNOMED CT46586006
UMLSC0263479
MedGen537915
GARD0022817
Is cancer (heuristic)no

Also known as: alopecia celsi · Cazenave’s vitiligo · Celsus’ vitiligo · Jonston’s alopecia · marginal alopecia · patchy alopecia

Disease family

This is a subtype of alopecia areata. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › disorder of pilosebaceous unithair anomalyalopeciaalopecia areatadiffuse alopecia areata

Related subtypes (1): alopecia areata 1

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.